SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-21-000870
Filing Date
2021-04-23
Accepted
2021-04-23 16:16:42
Documents
7

Document Format Files

Seq Description Document Type Size
1 c101011_defa14a.htm DEFA14A 49156
2 GRAPHIC x17_c101011x1x2.jpg GRAPHIC 37618
3 GRAPHIC x17_c101011x1x3.jpg GRAPHIC 5829
4 GRAPHIC x17_c101011x1x4.jpg GRAPHIC 3809
5 GRAPHIC x17_c101011x1x6.jpg GRAPHIC 7016
6 GRAPHIC x17_c101011x1x5.jpg GRAPHIC 5747
7 GRAPHIC x17_c101011x2x1.jpg GRAPHIC 1135
  Complete submission text file 0000930413-21-000870.txt   135362
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 21849900
SIC: 2834 Pharmaceutical Preparations